Clinical Trial Update: Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports results from a Phase 1 study of a four-drug combination (bortezomib, fluorouracil, leucovorin, and oxaliplatin) in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED